Improving Cognitive Screening Accuracy and Efficiency II: Application for Parkinsons disease (P6.307)

Conclusions:We demonstrate rapid, precise measurement of motor and cognitive components in PD that affords high classification accuracy in individuals performing in the normal range on the MMSE, offering an opportunity for sensitive, efficient cognitive monitoring.Disclosure: Dr. Davis has received personal compensation for activities with Digital Cognition Technologies, Inc. Dr. Davis has received royalty payments from Digital Cognition Technologies, Inc. Dr. Davis holds stock and/or stock options in Digital Cognition Technologies, Inc. Dr. Davis has received research support from Foxconn Corp. Dr. Souillard-Mandar has received personal compensation for activities with Digital Cognition Technologies, Inc. Dr. Au has nothing to disclose. Dr. Penney has received personal compensation for activities with Digital Cognition Technologies as its founder. Dr. Penney holds stock in Digital Cognition Technologies.
Source: Neurology - Category: Neurology Authors: Tags: Behavioral and Cognitive Neurology: Diagnostic Testing Source Type: research